Search
En
FR
DE
menu
en
ClientConnect
Close
ClientConnect
Search
Search
Who we are
back
Overview
back
EIB at a glance
back
Overview
Tackling global challenges together
Partners
Part of the EU family
Our priorities
back
Our results
back
Overview
EIB Group impact: Boosting GDP and jobs
Governance and structure
back
Overview
Shareholders
Statutory bodies
Control and evaluation
Organisation structure
Corporate responsibility
back
Overview
Providing finance
Borrowing
Human rights and the EIB
Reporting on sustainability
Our internal commitment
Managing our environment
Transparency, accountability and access to information
back
Overview
Transparency and access to information
EIB Group Complaints Mechanism overview
Project procurement complaints
Investigating fraud and misconduct
Evaluation
Public consultations
back
EIB Institute
back
What we offer
back
Overview
back
Loans
back
Overview
Loans for the public sector
Framework loans for the public sector
Loans for the private sector
Intermediated loans for SMEs, mid-caps and other priorities
Microfinance
Equity
back
Overview
Venture debt
Investments in infrastructure and environmental funds
Investments in SME and mid-cap funds
Guarantees
back
Overview
Credit enhancement for project finance
Guarantees in support of SMEs, mid-caps and other objectives
Advisory services
back
Mandates and partnerships
back
Overview
InvestEU
EU Blending facilities
Donor partnerships
Shared management funds and financial instruments
EFSD Guarantee
All mandates and partnerships
Our work
back
Overview
back
Our projects
back
All projects
Projects to be financed
Financed projects
Our priorities
back
Overview
Climate and environment
Digitalisation and technological innovation
Security and defence
A modern cohesion policy
Agriculture and bioeconomy
Social infrastructure
High-impact global investment
Capital Markets Union
Our regions of activity
back
Overview
European Union
Enlargement countries
Western Balkans
Eastern Neighbourhood
Southern Neighbourhood
Sub-Saharan Africa
Latin America and the Caribbean
Asia and the Pacific
EFTA countries
UK
Global investment map
back
Project cycle
back
Evaluation
back
Media centre
back
Overview
back
Newsroom
back
Overview
All releases
Press contacts
Stories and essays
back
Overview
Stories
Essays
Podcasts
All Cartoons
Video library
back
Events
back
Newsletter
back
Public register
back
EIB surveys
back
Overview
EIB climate survey
Picture library
back
Infographics
back
Our logo
back
Publications and research
back
Overview
back
Publications
back
Our research
back
Overview
Economic analysis
Surveys and data
Assessing EIB impact
Stories - Economics
Economic conferences and research networks
EIB open data
back
Open learning
back
Work with us
back
Overview
back
Careers
back
Overview
Diversity, Equity and Inclusion
Salary and benefits
Recruitment process
Investor Relations
back
Overview
Our funding
Climate and Sustainability Awareness Bonds
Recent issues
Outstanding issues
Investor relations news
Investor relations publications
Investor relations newsletters
Civil society and stakeholder engagement
back
Procurement
back
Contact us
back
Easy-to-read
back
back
The EIB at a glance
back
The EIB and development
back
The EIB and climate action
back
The EIB and SMEs
back
The EIB and Ukraine
back
The EIB COVID-19 response
back
Results
Top 5 search results
See all results
Advanced search
Top searches
Most visited pages
Home
Who we are
What we offer
Our work
Media centre
Publications and research
Work with us
Easy-to-read
Our work
Our projects
Our priorities
Our regions of activity
What we do
Global investment map
EFSI project list
Project cycle
Evaluation
All projects
Our projects
All projects
Projects to be financed
Financed projects
Financed projects
Breakdown by sector
Breakdown by region
PHARMACEUTICALS RDI PROGRAMME
Amount
€ 66,381,961.81
Sector(s)
Industry
: € 66,381,961.81
Countries
Poland
: € 66,381,961.81
Signature date(s)
29/06/2021
: € 66,381,961.81
Related press
Poland: EIB supports Polpharma’s research & development activities with a PLN 300 million loan (€65 million)
Project summary sheet(s)
PHARMACEUTICALS RDI PROGRAMME